NCT00656240View on ClinicalTrials.gov

To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

DE-104 ophthalmic solution

DRUG

DE-104 vehicle

Trial Locations (1)

Unknown

Osaka, Japan, Osaka

All Listed Sponsors
lead

Santen Pharmaceutical Co., Ltd.

INDUSTRY